The market is segmented based on , By Disease (Hypertension, Heart Failure, Heart Attack, Strokes, Diabetic Kidney Disease, Others), Dosage (Tablet, Liquid, Others), Dosage Strength (10mg/12.5mg, 20mg/12.5mg, 20mg/25mg, Others), Brand (Zestoretic, Prinivil, Zestril, Others), Population Type (Children, Adults), End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2031.
.
The Global Lisinopril Market size was valued at USD 217.10 USD Billion in 2022.
The Global Lisinopril Market is projected to grow at a CAGR of 4.3% during the forecast period of 2023 to 2030.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Belgium, Lithuania, Austria, Ireland, Norway, Poland, Italy, Spain, Russia, Turkey, Netherlands Switzerland, Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel and Rest of Middle East and Africa.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.
The data presented is for visualization purposes only and may not reflect actual results.
